Lv11
30 积分 2024-08-18 加入
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy
2小时前
已完结
Clinical Development of BRAF plus MEK Inhibitor Combinations
1天前
已完结
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
13天前
已完结
NTRK- and RET-fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake
13天前
已完结
The importance of the RET gene in thyroid cancer and therapeutic implications
17天前
已完结
Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities
21天前
已完结
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer
1个月前
已完结
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study
2个月前
已完结
Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer
2个月前
已完结
皖公网安备34019202002308
